APH vs TGTX · P/E 40, rev $16.38B vs P/E 18, rev $240.3M
Amphenol Corporation (APH) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2026-06-30 was $16.38B. Net income was $2.70B. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
APH currently screens at market cap $170.77B and trailing P/E 39.9. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the APH and TGTX stock pages for the full models.
Not investment advice.